ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,544,343, issued on Feb. 10, was assigned to Mucocort AB (Umea, Sweden).
"Treatment of inflammatory condition in mucous membrane or skin" was invented by Jean Lycke (Molnlycke, Sweden), Thomas Hedner (Vaxholm, Sweden), Mats Jontell (Boras, Sweden) and Olof Isaksson (Gothenburg, Sweden).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates a pharmaceutical composition comprising from 0.001 to 2% (w/v) of propane-1,2-diol as the only anti-inflammatory agent and at least one bioadhesive polymer. The pharmaceutical composition can be used in amelioration, prevention or treatment of an inflammatory condition in a mucous membrane or skin of a sub...